Loading
Total declarations
Companies
▲ Purchases (22 ops.)
▼ Sales (3 ops.)
Latest filing published 01 May 2017 for CAMBREX CORP.
Insider track record
Disclosed buys
22
Disclosed sells
3
Signal history
No signal scores available.
Closed purchases
Market purchases
22
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter G. Tombros: trading record in brief
Peter G. Tombros has filed trades across 6 companies (mainly through SEC (Form 4)), most often in NPS Pharmaceuticals Inc, Cambrex Corp and SFBC International Inc. The record holds 71 filings, for trades running from 30 December 2005 to 27 April 2017.
Both buying and selling appear: 22 purchases worth €212k, against 3 sales worth €1.5M. Taken together, the sales exceed the purchases by €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 37 share grants and 4 option exercises.
The median purchase comes to €7,766.
The latest filing, published on 1 May 2017, reports a share grant in Cambrex Corp. The last purchase on record was published on 30 March 2011, which is 5,686 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter G. Tombros
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations69 total
1,187 shares0Common StockSEC:0001437749-17-007619:0
1,330 shares0Common StockSEC:0000820081-16-000051:0
31,236 shares@ US$51.37Common StockSEC:0001007933-15-000001:0
7,980 shares0Common StockSEC:0001007933-15-000001:1
1,271 shares0Common StockSEC:0000820081-15-000019:0
57,625 shares@ US$46.00Common StockSEC:0001104659-15-013586:0
2,403 shares0Common StockSEC:0000820081-14-000017:0
2,000 shares@ US$10.58Common StockSEC:0000820081-14-000002:0
1,350 shares@ US$20.87Common StockSEC:0000820081-14-000002:1
3,956 shares0Common StockSEC:0000820081-13-000012:0
2,000 shares@ US$7.39Common StockSEC:0000820081-13-000004:0
15,225 sharesCommon stockSEC:0001474064-13-000026:0
31,070 sharesCommon StockSEC:0000820081-12-000028:0
8,699 shares@ US$11.28Common StockSEC:0000820081-12-000028:1
5,961 shares0Common StockSEC:0000820081-12-000015:0
2,000 shares@ US$4.72Common StockSEC:0000820081-12-000007:0
15,225 shares0Common StockSEC:0001474064-12-000026:0
7,634 shares0Common StockSEC:0000820081-11-000014:0
1,803 shares@ US$5.83Common stockSEC:0001474064-11-000003:0
Canonical exit: 21 Feb 2011 (T+90)
3,387 shares@ US$5.84Common stockSEC:0001474064-11-000003:1
Canonical exit: 21 Feb 2011 (T+90)
3,531 shares@ US$5.85Common stockSEC:0001474064-11-000003:2
Canonical exit: 21 Feb 2011 (T+90)
200 shares@ US$6.21Common stockSEC:0001474064-11-000002:0
Canonical exit: 17 Feb 2011 (T+90)
800 shares@ US$6.22Common stockSEC:0001474064-11-000002:1
Canonical exit: 17 Feb 2011 (T+90)
1,903 shares@ US$6.23Common stockSEC:0001474064-11-000002:2
Canonical exit: 17 Feb 2011 (T+90)
1,786 shares@ US$6.24Common stockSEC:0001474064-11-000002:3
Canonical exit: 17 Feb 2011 (T+90)
25 of 69 declarations
